Treatment Options for Hodgkin's Disease During Pregnancy

References

• O'Dell R. F. Leukemia and lymphoma complicating pregnancy. Clin. Obstet Gynecol. 1979; 22: 859–870
   PubMedGoogle Scholar
• Stewart H. L., Monto R. W. Hodgkin's disease and pregnancy. Am. J. Obstet. & Gynecol. 1952; 63: 570–578
   PubMed Web of Science ®Google Scholar
• Palacios Costa N., Chavanne F. C., Zebel Fernandez D. An de ateneo, Buenos Aires 1945; 127
   Google Scholar
• Davis A. B. Report of a case of Hodgkin's disease complicated by pregnancy. Bull Lying-in Hospital, NY. 1911; 7: 151–158
   Google Scholar
• Bichel J. Hodgkin's disease and pregnancy. Acta Rasdiol. 1950; 33: 427–434
   PubMed Web of Science ®Google Scholar
• Gemmel A. A. Hodgkin's disease during pregnancy. J. Obstet. & Gynecol. Br. Emp. 1923; 30: 373–376
   Google Scholar
• Southam C. M., Diamond H. D., Carver L. F. Hodgkin's disease in pregnancy. Cancer 1962; 9: 1141–1146
   Web of Science ®Google Scholar
• Barry R. M., Diamond H. D., Carver L. F. Influence of pregnancy on the course of Hodgkin's disease. Am. J. Obstet. Gynecol. 1962; 84: 445–454
   PubMed Web of Science ®Google Scholar
• Hennessy J. P., Rottino A. Hodgkin's disease in pregnancy. Am. J. Obstet. Gynecol 1963; 87: 851–853
   PubMedGoogle Scholar
• Priesel A., Winkelbauer A. Placetnare ubertragung des lymphogranulomas. Virch. Arch. 1926; 262, 749 796
   Google Scholar
• Rosenberg S. A., Kaplan H. S., Glatstein E. J., Portlocl C. S. Combined modality therapy of Hodgkin's diseaw A report on the Stanford trials. Cancer 1978; 42: 991–1000
   PubMed Web of Science ®Google Scholar
• Kinsella T. J., Glatstein E. J. Staging laparotorn and splenectomy for Hodgkin's disease: Current status. Cancer Invest. 1983; 1: 93–99
   PubMed Web of Science ®Google Scholar
• DeVita V. T., Jaffe E. S., Hellman S. Hodgkin disease. Cancer: Principles and Practice of Oncology (3rd edition). B., V. T. DeVita, S Hellman, S. A Rosenberg. Lippincott Company, Philadelphia 1989
   Google Scholar
• Covington E. E., Baker A. S. Dosimetry of scattere radiation to the fetus. JAMA 1969; 209: 414–415
   PubMed Web of Science ®Google Scholar
• Thomas P. R. M., Peckham M. J. The investigatio and management of Hodgkin's disease in the pregnant patien. Cancer 1976; 34: 1443–1451
   Web of Science ®Google Scholar
• Conley J. O., Jacobson A. Modified radiation therapy regimen for Hodgkin's disease in the third trimester of pregnancy. Am. J. Roentgenol. 1977; 128: 666–677
   PubMed Web of Science ®Google Scholar
• Smith H. N., Spaulding L. Hodgkin's disease in pregnane;. South Med. J., 71: 374–376
   PubMedGoogle Scholar
• Jacobs G., Donaldson S. S., Rosenberg S. A., Kaplan I S. Management of the pregnant patient with Hodgkin. disease. 1981; 95: 669–675
   Google Scholar
• Tawil E., Mercier J. P., Dandavino A. Hodgkin disease complicating pregnant. J. Can. Assoc. Radiol. 1985; 10: 803–809
   Google Scholar
• Nisce L. Z., Tome M. A., He S., Lee B. J., Kutcher G. Management of co-existing Hodgkin's disease an pregnancy. Am. J. Clin. Oncol. 1986; 9: 146–151
   PubMed Web of Science ®Google Scholar
• Becker M. H., Hyman G. A. Management Hodgkin's disease coexistent with pregnancy. Radiology. 1965; 8: 725–728
   Google Scholar
• Zucali R., Marchesini R., DePalo O. Abdomia dosimetry for supradiaphragmatic irradiation of Hodgkin disease in pregnancy. Experimental data and clinical considerations. Tumori. 1981; 67: 203–208
   PubMed Web of Science ®Google Scholar
• Wong P. S., Rosemark P. J., Exler M. C., Greenberg S. I, Thompson R. W. Doses to organs at risk from mantle field radiation therapy using 10 MV x-rays. Mt. Sin J. Med. 1985; 52: 216–220
   PubMed Web of Science ®Google Scholar
• Fraass B. A., Vende A., Geign J. Peripheral dose from megavoltage beam. Med. Phys. 1983; 10: 809–818
   PubMed Web of Science ®Google Scholar
• Sharma S. C., Williamson J. F., Khan F. M., Lee C. I. K. Measurement and calculation of ovary and fetus do in extended field radiotherapy for 10 MV x-rays. Int. Rod. Oncol biol Phys. 1981; 7: 843–846
   PubMed Web of Science ®Google Scholar
• DeVita V. T., Simon R. M., Hubbard S. M. Curability of advanced Hodgkin's disease with chemotherap Long term follow up of MOPP treated patients at NCI. An Intern. Med. 198?; 82: 587–595
   PubMedGoogle Scholar
• Boland J. Clinical experience with nitrogen mustard Hodgkin's disease. Br. J. Radiol. 1951; 24: 513–515
   PubMed Web of Science ®Google Scholar
• Riva H., Anderson P. S., O'Grady J. S. Pregnani and Hodgkin's disease. Am. J. Obstet. Gynecol. 1955; 66: 877–880
   Google Scholar
• Zoet A. G. Pregnancy complicating Hodgkin's disease. Northwest Med. 1964; 49: 373–374
   Google Scholar
• Smith R. B., Sheehy T. W., Rothberg H. Hodgkir disease and pregnancy. Arch. Intern. Med. 1958; 102: 2777–2789
   Google Scholar
• Wright J. C. The effect of triethylene melamine and triethylene phosphoramide in hyman neoplastic disease. Act Unio Internal. Cancer 1955; 11: 220–257
   PubMedGoogle Scholar
• Shotton D., Monie I. W. Possible teratogenic effect of chlorambucil on a human fetus. JAMA 1963; 186: 74–75
   PubMed Web of Science ®Google Scholar
• Greenberg L. H., Tanaka K. R. Congenit abnormalities probably induced by cyclophosphamide. JAM. 1964; 188: 423–426
   PubMed Web of Science ®Google Scholar
• Well J. H., Marshal J. R., Carbone P. P. Procarbazine therapy for Hodgkin's disease in early pregnancy. JAMA 1968; 205: 423–426
   Google Scholar
• Armstrong J. D., Dyke R. W., Fouts P. J., Jansen C. J. Delivery of a normal infant during the course of oral Vinblastine therapy for Hodgkin's disease. Ann. Intern. Med. 1964; 61: 16–107
   Google Scholar
• Goguel A. Hodgkin's disease and pregnancy. Presse Med. 1970; 78: 1507–1510
   PubMed Web of Science ®Google Scholar
• Lacker M. J. Use of Vinblastine Sulfate to treat Hodgkin's disease during pregnancy. Ann. Inter. Med. 1964; 61: 106–107
   PubMedGoogle Scholar
• Nordlund J. J., DeVita V. T., Carbone P. P. Severe Vinblastine induced leukopenia during late pregnancy with delivery of a normal infant. Ann. Intern. Med., 69: 581–582
   PubMed Web of Science ®Google Scholar
• Rosenzweig A. L., Cres Q. E., Hopwood H. G. Vinblastine sulfate in Hodgkin's disease in pregnancy. Ann. Intern. Med. 1964; 61: 108–112
   PubMed Web of Science ®Google Scholar
• Shepherd J., Wright D. H. Burkitt's tumor presenting as bilateral swelling of the breast in 20 women of child-bearing age. Br. J. Surg. 1967; 54: 776–780
   PubMed Web of Science ®Google Scholar
• Garrett M. H. Teratogenic effect of “bination chemotherapy”. Ann. Int. Med. 1974; 80: 667
   PubMed Web of Science ®Google Scholar
• Menutti M. T., Shepard T. H., Mellman W. J. Fetal malformation following treatment of Hodgkin's disease during pregnancy. Obstet. Gynecol. 1975; 46: 194–196
   PubMed Web of Science ®Google Scholar
• Daly H., McCann S. R., Hanratty T. D., Temperley I. J. Successful pregnancy during combination chemotherapy for Hodgkin's disease. Acta Haematol. 1980; 64: 154–156
   PubMed Web of Science ®Google Scholar
• Johnson I. R., Filshie G. M. Hodgkin's disease diagnosed in pregnancy. Br. J. Obstet. Gynecol. 1977; 84: 791–792
   PubMedGoogle Scholar
• Bill A. B., Forgotson E. H. Radiation and congenital malformations. Am. J. Obstet. Gynecol. 1964; 90: 1149–1168
   PubMed Web of Science ®Google Scholar
• Sweet D. L., Kunzie J. Consequences of radiotherapy and antineoplastic therapy for the fetus. J. Reprod. Med. 1976; 17: 242–246
   Google Scholar
• Cowen D., Geller M. L. Long term pathological effects of prenatal x-irradiation on the central nervous system of the rat. J. Neuropathol. Exp. Neurol. 1960; 19: 488–504
   PubMed Web of Science ®Google Scholar
• Plummer G. V. Anomalies occurring in children exposed in utero to the atom bomb in Hiroshima. Ped. 1952; 10: 687–693
   PubMed Web of Science ®Google Scholar
• Blot W. J., Miller R. W. Mental retardation following in utero exposure to the atomic bombs of Hiroshima and Nagasaki. Radiology 1973; 106: 617–619
   PubMed Web of Science ®Google Scholar
• Goldstein L., Murphy D. P. Etiology of the ill health in children born after maternal pelvic irradiation. Amer. J. Roentgenol. Gynecol. 1929; 22: 322–331
   Google Scholar
• Dekaban A. S. Abnormalities in children exposed to x-irradiation during various stages of gestation: Tentative time table of radiation injury to human fetus, Part I. J. Nucl. med. 1968; 9: 471–477
   PubMed Web of Science ®Google Scholar
• Doll D. C., Rigenberg Q. S., Yarbro J. W. Management of cancer during pregnancy. Arch. Intern. Med. 1988; 148: 2058–2064
   PubMed Web of Science ®Google Scholar
• Hammer-Jacobson E. Therapeutic abortion on account of x-ray examination during pregnancy. Dan. Med. Bull. 1959; 6: 113–122
   PubMedGoogle Scholar
• Brent R. L. The effects of embryonic and fetal exposure to x-ray, microwaves, and ultrasound. Clin. Perinatal. 1986; 13: 615–648
   PubMed Web of Science ®Google Scholar
• Chaube S., Krug G., Murphy M. L. Teratogenic effects of cyclophosphamide (NSC-26271) in the rat. Cancer Chemother. Rep. 1976; 51: 363–376
   Google Scholar
• Gibson J. E., Becker B. A. The teratogenicity of cyclophosphamide in mice. Cancer Res. 1968; 28: 475–480
   PubMed Web of Science ®Google Scholar
• Nicholson D. Cytotoxic drugs in pregnancy. J. Obstet. Gynecol. Br. Commonwealth. 1968; 75: 307–312
   PubMedGoogle Scholar
• Kalter H., Warkeny J. Congenital malformations. New Engl. J. Med. 1983; 308: 424–431
   PubMed Web of Science ®Google Scholar
• Reynoso E. E., Shepherd F. A., Messner H. A., Farquharson H. A., Garvey M. B., Baker M. A. Acute leukemia during pregnancy: The Toronto leukemia study group experience with long-term follow up of children exposed in utero to chemotherapeutic agents. J. Clin. Oncol. 1987; 5: 1098–1106
   PubMed Web of Science ®Google Scholar
• Wagner L. K., Archer B. R., Zeck O. F. Conceptus dose from two state of the art CT scanners. Radiology 1986; 59: 787–792
   Google Scholar
• Peters M. V., Allison R. E., Buch R. S. Natural history of Hodgkin's disease as related to staging. Cancer 1966; 19: 308–346
   Web of Science ®Google Scholar
• Ferm V. J. Congenital malformation in hamster embryos after treatment with Vinblastine and vincristine. Science 1963; 141: 414–426
   PubMed Web of Science ®Google Scholar
• Hellman S., Mauch P. Role of radiation therapy in the treatment of Hodgkin's disease. Cancer Treat. Rep. 1982; 66: 915–923
   PubMedGoogle Scholar
• Mauch P., Ryback M. E., Rosenthal D. The influence of initial pathological stage on the survival of patients who relapse from Hodgkin's disease. Blood. 1980; 56: 892–907
   PubMed Web of Science ®Google Scholar
• Porzig K. J., Portlock C. S., Robertson A. Treatment of advanced Hodgkin's disease with B-cave following MOPP failure. Cancer 1978; 41: 1670–1675
   PubMed Web of Science ®Google Scholar
• Santoro A., Bonfante V., Bonadonna G. Salvage chemotherapy with ABVD in MOPP resistant Hodgkin's disease. Ann. Intern. Med. 1982; 96: 139–143
   PubMed Web of Science ®Google Scholar
• Musshof K., Boutis L. Therapy results in Hodgkin's disease. Cancer 1968; 21: 1100–1103
   PubMed Web of Science ®Google Scholar
• Prosnitz L. R., Hellman S., Von Essen C. F., Kligerman M. M. The clinical course of Hodgkin's disease and other malignant lymphomas treated with radical radiation therapy. Am. J. Roentgenol. 1969; 105: 618–638
   Web of Science ®Google Scholar
• Frei E., Geham E. A. Definition of cure for Hodgkin's disease. Cancer Res. 1971; 31: 1828–1833
   PubMed Web of Science ®Google Scholar